Mankind Pharma Ltd.
13Patents
13Active
13Granted
49Portfolio score
Filing activity: Sep 10, 2015 → Jun 7, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10208030B2 | GPR119 agonist compounds | Chemistry; Metallurgy | 2 | Active |
| US11318183B2 | Stable pharmaceutical composition of vasopressin | Human Necessities | 1 | Active |
| US11382866B2 | Fixed dose pharmaceutical composition of valsartan and sacubitril | Human Necessities | 1 | Active |
| US10526345B2 | Compounds as GPR119 agonists | Chemistry; Metallurgy | 0 | Active |
| US11707502B2 | Stable pharmaceutical composition of vasopressin | Human Necessities | 0 | Active |
| US10239833B2 | Intermediates, their process and use in preparation of selective α1-adrenoceptor antagonists, Silodosin | Chemistry; Metallurgy | 0 | Active |
| US10167271B2 | Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride | Chemistry; Metallurgy | 0 | Active |
| US11246862B2 | Process for the preparation of lifitegrast | Chemistry; Metallurgy | 0 | Active |
| US10954229B2 | GPR119 agonist compounds | Chemistry; Metallurgy | 0 | Active |
| US10377710B2 | Process for the preparation of considerably pure Silodosin | Electricity | 0 | Active |
| US10919915B2 | Compounds as GPR119 agonists | Chemistry; Metallurgy | 0 | Active |
| US11819577B2 | Fixed dose pharmaceutical composition of valsartan and sacubitril | Human Necessities | 0 | Active |
| US10752622B2 | GPR119 agonist compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.